Maria Laskou retweeted
Should antiplatelet agents be given alongside lipid-lowering therapies after artery stent procedure?
Edward A. Fisher & team @nyugrossman discover platelets hinder inflammation resolution in atherosclerotic plaques after lipid-lowering treatment in insulin-resistant mice: insight.jci.org/articles/vie…
#Atherosclerosis
The figure shows smaller necrotic cores in plaques from platelet-depleted mice (right).
Maria Laskou retweeted
How diet influences atherosclerosis in obesity…
@AWeinstock & team @nyugrossman show short-term caloric restriction resolves #atherosclerosis inflammation in obese mice, but weight regain accelerates its adverse effects: jci.org/articles/view/172198
The figure shows weight regain reverts Fcgr4+ macrophage levels to obese proportions and accelerates atherosclerosis progression in aortic root sections from a mouse model.
Maria Laskou retweeted
🩷The June issue is out🩷
Read about #cardiac #metabolite signaling, #endothelial flow sensing, systems #immunology-based #drugrepurposing to treat #atherosclerosis, #PAH and #sotatercept, and much more!
Cover image @GiannarelliL
Another exciting poster session! One more opportunity to talk about platelets and atherosclerosis regression😊 Thanks @NYULHCVRC for organizing!
Maria Laskou retweeted
Nearly half of American adults have high blood pressure, putting them at higher risk for stroke and heart disease. The only way to know if your BP is in a normal range is to measure it. #WorldHypertensionDay #StrokeMonth
Thank you @AHAMeetings and #VascularDiscovery2023 for the really wonderful poster session yesterday night!
I had so much fun presenting my first poster ever (!) on platelets’ role on atherosclerosis regression!
Maria Laskou retweeted
Did you know that yoyo dieting is bad for your❤️?
In our new #BioRxiv we show how #weightloss resolves 🫀 disease and that weight regain heightens inflammation in the🦴marrow.
Comment 👇to let us know what u think!🧵 1/n
biorxiv.org/content/10.1101/…
